Possible Mechanisms in Hepatocarcinogensis by the Peroxisome Proliferator Di(2-Ethylhexyl)Phthalate

References

• Reddy J. K., Lalwani N. D. Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit. Rev. Toxicol. 1983; 12: 1–58
   Web of Science ®Google Scholar
• National Toxicology Program. (NTP Technical Report Series No. 217). Carcinogenesis bioassay of di(2-ethylhexyl)phthalate in F-344 rats and B6C3F1 mice. National Institutes of Health, Bethesda, MD 1982a
   Google Scholar
• Tennant R. W., Margolin B. H., Shelby M. D., Zeiger E., Haseman J. K., Spaulding J., Caspary W., Resnick M., Stasiewicz S., Anderson B., Minor R. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays. Science 1987; 236: 933–941
   PubMed Web of Science ®Google Scholar
• Butterworth B. E. Nongenotoxic Mechanisms in Carcinogenesis (Banbury Report 25), T. J. Slaga. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1987; 397
   Google Scholar
• Butterworth B. E. The genetic toxicology of di(2-ethylhexyl)phthalate(DEHP). Nongenotoxic Mechanisms in Carcinogenesis (Banbury Report 25), B. E. Butterworth, T. J. Slaga. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 1987; 257–276
   Google Scholar
• Griesemer R. A., Harper C., Calabrese E., Michalopoulos G., Rosenkranz H. S., Schneiderman M., Sipes I. G. Chronic hazard advisory panel on di(2-ethylhexyl)phthalate (DEHP). Report to the U.S. Consumer Product Safety Commission, Washington, DC September, 1985
   Google Scholar
• Turnbull D., Rodricks J. V. Assessment of possible carcinogenic risk to humans resulting from exposure to di(2-ethylhexyl)phthalate (DEHP). J. Am. Coll. Toxicol. 1985; 4: 111–145
   Google Scholar
• Drinking Water and Health. National Academy Press, Washington, DC 1986; 338–358
   Google Scholar
• Warren J. R., Simmon V. F., Reddy J. K. Properties of hypolipidemic peroxisome proliferators in the lymphocyte [3H]thymidine and Salmonella mutagenesis assays. Cancer Res. 1980; 40: 36–42
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Lalwani N. D., Reddy M. K., Qureshi S. Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenicity by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cancer Res. 1982; 42: 259–266
   PubMed Web of Science ®Google Scholar
• Glauert H. P., Reddy J. K., Kennan W. S., Sattler G. L., Rao V. S., Pitot H. C. Effect of hypolipidemic peroxisome proliferators on unscheduled DNA synthesis in cultured hepatocytes and on mutagenesis in Salmonella. Cancer Lett. 1984; 24: 147–156
   PubMed Web of Science ®Google Scholar
• Cattley R. C., Richardson K. K., Smith-Oliver T., Popp J. A., Butterworth B. E. Effect of peroxisome proliferator carcinogens on unscheduled DNA synthesis in rat hepatocytes determined by auto-radiography. Cancer Lett. 1986; 33: 269–277
   PubMed Web of Science ®Google Scholar
• Cattley R. C., Smith-Oliver T., Butterworth B. E., Popp J. A. Failure of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis in rat hepatocytes following in vivo treatment. Carcinogenesis 1988; 9: 1179–1183
   PubMed Web of Science ®Google Scholar
• Bridges B. A., Butterworth B. E. Indicators of Genotoxic Exposure (Banbury Report 13), I. B. Weinstein. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1982; 580
   Google Scholar
• Chemical Manufacturers Association (CMA). Health effects testing, phase I: Validation results. Phthalate esters program panel, voluntary test program, G. B. Cox, E. J. Moran. Chemical Manufacturers Association, Washington, DC 1982; Vol. 1
   Google Scholar
• Putman D. L., Moore W. A., Schechtman L. M., Hodgson J. R. Cytogenetic evaluation of di(2-ethylhexyl)phthalate and its major metabolites in Fischer 344 rats. Environ. Mutgen 1983; 5: 227–231
   PubMedGoogle Scholar
• Buttenvorth B. E., Bermudez E., Smith-Oliver T., Earle L., Cattley R., Martin J., Popp J. A., Strom S., Jirtle R., Michalopoulos G. Lack of genotoxic activity of di(2-ethylhexyl)phthalate (DEHP) in rat and human hepatocytes. Carcinogenesis 1984; 5: 1329–1335
   PubMed Web of Science ®Google Scholar
• Lutz W. K. Investigation of the potential for binding of di(2-ethylhexyl)phthalate (DEHP) to rat liver DNA in vivo, Environ. Health Perspect. 1986; 65: 267–269
   Google Scholar
• Elliott B. M., Elcombe C. R. Lack of DNA damage or lipid peroxidation measured in vivo in the rat liver following treatment with peroxisomal proliferators. Carcinogenesis 1987; 8: 1213–1218
   PubMed Web of Science ®Google Scholar
• Goel S. K., Lalwani N. D., Fahl W. E., Reddy J. K. Lack of covalent binding of peroxisome proliferators nafenopin and Wy-14,643 to DNA in vivo and in vitro, Toxicol. Lett. 1985; 24: 37–43
   Google Scholar
• Gupta R. C., Goel S. K., Earley K., Singh B., Reddy J. K. 32P-Post-labeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and in hepatocytes in vitro. Carcinogenesis 1985; 6: 933–936
   PubMed Web of Science ®Google Scholar
• Garvey L. K., Swenberg J. A., Hamm T. E., Popp J. A. Di(2-ethylhexyl)phthalate: Lack of initiating activity in the liver of female F-344 rats. Carcinogenesis 2987; 8: 285–290
   Google Scholar
• Cayama E., Tsuda H., Sarma D. S.R., Farber E. Initiatio of chemical carcinogenesis requires cell proliferation. Nature 1978; 275: 60–62
   PubMed Web of Science ®Google Scholar
• Tsuda H., Lee G., Farber E. Induction of resistant hepatocytes as a new principle for a positive short-term in vivo test for carcinogens. Cancer Res. 1980; 40: 1157–1164
   PubMed Web of Science ®Google Scholar
• Glauert H. P., Beer D., Rao M. S., Schwarz M., Xu Y., Goldsworthy T. L., Coloma J., Pitot H. C. Induction of altered hepatic foci in rats by the administration of hypolipidemic peroxisome proliferators alone or following a single dose of diethyinitrosamine. Cancer Res. 1986; 46: 4601–4606
   PubMed Web of Science ®Google Scholar
• Rao M. S., Lalwani N. D., Reddy J. K. Sequential histologic study of rat liver during peroxisome proliferator [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio-acetic acid (WY-14,643)-induced carcinogenesis. J. Natl. Cancer Inst. 1984; 73: 983–990
   PubMed Web of Science ®Google Scholar
• Préat V., Lans M., decerlache J., Taper H., Roberfroid M. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis. Gann 1986; 77: 629–638
   PubMedGoogle Scholar
• Rao M. S., Lalwani N. D., Scarpelli D. G., Reddy J. K. The absence of γ-glutamyl transpeptidase activity in putative preneoplastic lisions and in hepatocellular carcinomas induced in rats by the hypolipidemic peroxisome proliferator WY-14,643. Carcinogenesis 1982; 3: 1231–1233
   PubMed Web of Science ®Google Scholar
• Rao M. S., Usuda N., Subbarao V., Reddy J. K. Absence of γ-glutamyltranspeptidase activity in neoplastic lesions induced in the liver of male F-344 rats by di(2-ethylhexyl)phthalate, a peroxisome proliferator. Carcinogenesis 1987; 8: 1347–1350
   PubMed Web of Science ®Google Scholar
• Rao S. M., Subbaro V., Reddy J. K. Peroxisome proliferator-induced hepatocarcinogenesis: Histochemical analysis of ciprofibrate-induced preneoplastic and neoplastic lesions for γ-glutamyl trans-peptidase activity. J. Natl. Cancer Inst. 1986; 77: 951–956
   PubMed Web of Science ®Google Scholar
• Ward J. M., Diwan B. A., Ohshima M., Hu H., Schuller H. M., Rice J. M. Tumor-initiating and promoting activities of di(2-ethylhe-xyl)phthalate in vivo and in vitro, Environ. Health Perspec. 1986; 65: 279–291
   Google Scholar
• Frazells J. H., Abernethy D. J., Boreiko C. J. Enhanced sensitivity of the C3H/10T1/2 cell transformation system to alkylating and chemotherapeutic agents by treatment with 12-O-tetradecanoylphor-bol-13-acetate Environ. Mutagen. 1984; 6: 81–89
   Web of Science ®Google Scholar
• Sanchez J. H., Abernethy D. J., Boreiko C. J. Lack of di(2-ethylhexyl)phthalate activity in the C3H/10T/1/2 cell transformation system.Toxicol. In Vitro 1987; 1: 49–53
   Google Scholar
• Matthews E. J., DelBalzo T., Rundell J. O. Assays for morphological transformation and mutation to oubain resistance of Balb/3T3 cells in culture, Prog. Mutat. Res. 1985; 5: 639
   Google Scholar
• Barrett C. J., Wong A., McLachlan J. A. Diethylstilbestrol induces neoplastic transformation of cells in culture without measureable somatic mutation at two lici. Science 1981; 212: 1402–1404
   PubMed Web of Science ®Google Scholar
• Hesterberg T. W., Barrett C. J. Dependence of asbestos- and mineral dust-induced transformation of mammalian cells in culture on fiber dimension. Cancer Res. 1984; 44: 2170–2180
   PubMed Web of Science ®Google Scholar
• Barrett C. J., Hesterberg T. W., Thomassen D. G. Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis. Pharmacol. Rev 1984; 36: 53S–70S
   PubMedGoogle Scholar
• Barrett C. J., Lamb P. W. Tests with the Syrian hamster embryo cell transformation assay. Prog. Mutat. Res. 1985; 5: 623–628
   Google Scholar
• Sanner T., Rivedal E. Tests with the Syrian hamster embryo (SHE) cell transformation assay. Prog. Mutat.Res. 1985; 5: 665–671
   Google Scholar
• Ashby J., de Serres F, Draper M., Ishidate J., Margolin B., Matter B., Shelby M. Evaluation of short-term tests for carcinogenesis. Prog. Mutat. Res. 1985; 5: 752
   Google Scholar
• Parry E. M. Tests for effects on mitosis and the mototic spindle in Chinese hamster primary liver cells (CH1-L) in culture. Evaluation of short-term tests for carcinogenesis. Prog. Mutat. Rex 1985; 5: 474–485
   Google Scholar
• Woodward K. N. Phthalate Esters: Toxicity and Metabolism. CRC Press, Boca Raton, FL 1988; Vol. 1 and 2
   Google Scholar
• Cattley R. C., Conway J. G., Popp J. A. Association of persistent peroxisome proliferation and oxidative injury with hepatocarcinogenicity in female F344 rats fed di(2-ethylhexyl)phthalate for 2 years. Cancer Lett. 1987; 38: 15–22
   PubMed Web of Science ®Google Scholar
• Tomaszewski K. E., Aganval D. K., Melnick R. L. In vitro steady-state levels of hydrogen peroxide after exposure of male F-344 rats and female B6C3F1 mice to hapatic peroxisome proliferators. Carcinogenesis 1986; 7: 1871–1876
   PubMed Web of Science ®Google Scholar
• Mitchell F. E., Price S. G., Hinton R. H., Grasso P., Bridges J. W. Time and dose-response study of the effects on rats of the plasticizer di(2-ethylhexyl)phthalate. Toxicol. Appl. Pharmacol. 1985; 81: 371–392
   PubMed Web of Science ®Google Scholar
• Lake B. G., Kozlen S. L., Evans J. G., Gray T. J.B., Young P. J., Gangolli S. D. Effect of prolonged administration of clofibric acid and di(2-ethylhexyl)phthalate on hepatic enzyme activities and lipid peroxidation in the rat. Toxicology 1987; 44: 213–228
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Reddy M. K., Usman M. I., Lalwani N. D., Rao M. S. Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl)adipate with a hypolipidemic drug Environ. Health Perspect. 1986; 64: 317–327
   Google Scholar
• Marsman D. S., Cattley R. C., Conway J. G., Popp J. A. Relationship of peroxisome proliferation and cell proliferation to the hepatocarcinogenicity of the peroxisome proliferators, di(2-ethylhe-xyl)phthalate and Wy-14,643. Cancer Rex 1988, in press.
   PubMedGoogle Scholar
• Perera M. I., Katyal S. L., Shinozuka H. Suppression of choline-deficient diet-induced hepnatocyte membrane lipid peroxidation in rats by the peroxisome proliferators 4-chloro-6-(2,3-xylidino)-2-pyrimidi-nylthio (N- β-hydroxyethyl) acetamide and di(2-ethylhexyl)phthalate). Cancer Res. 1986; 46: 3304–3308
   PubMed Web of Science ®Google Scholar
• Hawkins J. M., Jones W. E., Bonner F. W., Gibson G. G. The effect of pereoxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab. Rev. 1987; 18: 441–515
   PubMed Web of Science ®Google Scholar
• Rao M. S., Reddy J. K. Peroxisome proliferation and hepatocarcinogenesis. Carcinogenesis 1987; 8: 631–636
   PubMed Web of Science ®Google Scholar
• Ochi T., Cerutti P. A. Clastogenic action of hydroperoxy-5,8,11,13-icosatetraenoic acids on the mouse embryo fibroblasts C3H/10T1/2. Proc. Natl. Acad. Sci. 1987; 84: 990–994
   PubMed Web of Science ®Google Scholar
• Hornsby P. J., Harris S. E. Oxidative damage to DNA and replicative lifespan in cultured adrenocortical cells. Exp. Cell. Res. 1987; 168: 203–217
   PubMed Web of Science ®Google Scholar
• Alexson S. A., Cannon B. A direct comparison between peroxisomal and mitochondrial preferences for fatty-acyl P-oxidation predicts channeling of medium-chain and very-long-chain unsaturated fatty acids to peroxidation. Biochem. Biophys. Acta 1984; 796: 1–10
   PubMed Web of Science ®Google Scholar
• Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 1979; 59: 527–605
   PubMed Web of Science ®Google Scholar
• Foerster E., Fahrenkemper T., Rabe U., Graf P., Sies H. Peroxisomal fatty acid oxidation as detected by H2O2 production in intact perfused rat liver. Biochem. J. 1981; 196: 705–712
   PubMed Web of Science ®Google Scholar
• Handler J. A., Thurman R. G. Catalase-dependent ethanol oxidation in perfused rat liver: Requirement for fatty acid-stimulated H2O2 production by peroxisomes. Eru. J. Biochem. 1988, in press.
   Google Scholar
• Conway J. G., Neptun D. A., Garvey L. K., Popp J. A. Role of fatty acyl-CoA oxidase in the efflux of oxidized glutathione from perfused livers from rats treated with the peroxisome proliferating compound nafenopin. Cancer Res. 1987; 47: 4795–4800
   PubMed Web of Science ®Google Scholar
• Lalwani N. D., Reddy M. K., Qureshi S. A., Reddy J. K. Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed [4-chloro-6-(2,3-xylindino)-2-pyrimi-dinylthiolacetic acid (Wy, 14,643) in the semipurified diet. Carcinogenesis 1981; 2: 645–650
   PubMed Web of Science ®Google Scholar
• Goel S. K., Lalwani N. D., Reddy J. K. Peroxisome proliferation and lipid peroxidation in rat liver. Cancer Res. 1986; 46: 1324–1330
   PubMed Web of Science ®Google Scholar
• Brizzee K. R., Ordy J. M. Cellular features, regional accumulation, and prospects of modification of age pigments in mammals. Age Pigments, R. S. Sohal. Elsevier/North-Holland Biomedical Press. 1981; 102–145
   Google Scholar
• Chio K. S., Reiss U., Fletcher B. L., Tappel A. L. Peroxidation of subcellular organelles: Formation of lipofuscin-like fluorescent pigments. Science 1969; 166: 1535–1536
   PubMed Web of Science ®Google Scholar
• Conway J. G., Tomaszewski K. E., Olson M. J., Cattley R. C., Marsman R. L., Popp J. A. Relationship of oxidative damage to the hepatocarcinogenicity with the peroxisome proliferators di(Zethylhe-xyl)phthalate and Wy-14,643. Carcinogenesis 1988, in press.
   Web of Science ®Google Scholar
• Price S. C., Hinton R. H., Mitchell F. E., Hall D. E., Grasso P., Blane G. F., Bridges J. W. Time and dose study on the response of rats to the hypolipidemic drug fenofibrate. Toxicology 1986; 41: 169–191
   PubMed Web of Science ®Google Scholar
• Conway J. G., Popp J. A. in vivo ethane exhalation and lipofuscin accumulation in livers of rats fed the peroxisome proliferator Wy-14,643. Proc. Amer. Assoc. Cancer Rex 1988; 29, abstract 608
   Google Scholar
• Smith M. T., Thor H., Hartzell P., Orrenius S. The measurement of lipid peroxidation in isolated hepatocytes. Biochem. Pharmacol. 1982; 31: 19–26
   PubMed Web of Science ®Google Scholar
• Ekstrom T., Stahl A., Sigvardson K., Hogberg J. Lipid peroxidation in vivo monitored by ethane exhalation and malondialdehyde excretion in the urine after oral administration of chloroform. Acta Pharmacol. Toxicol. 1986; 58: 289–296
   PubMedGoogle Scholar
• Hietanen E., Ahotupa M., Bereziat J., Bussacchini V., Carnus A., Bartsch H. Elevated lipid peroxidation in rats induced by dietary lipids and N-nitrosodimethylamine and its inhibition by indomethacin monitored via ethane exhalation 1987; 15: 93–96
   Google Scholar
• Smith C. V. Evidence for participation of lipid peroxidation and iron in diquat-induced hepatic necrosis. in vivo, Mol. Pharmacol. 1987; 32: 417–422
   PubMed Web of Science ®Google Scholar
• Lindstrom T. D., Anders M. W. Effects of agents known to alter carbon tetrachloride hepatotoxicity and cytochrome P-450 levels on carbon tetrachloride-stimulated lipid peroxidation and ethane expiration in the intact rat. Biochem. Pharmacol. 1978; 27: 563–567
   PubMed Web of Science ®Google Scholar
• Hughes H., Smith C. V., Homing E. C., Mitchell J. R. High-performance liquid chromatography and gas chromatography-mass spectrometry determination of specific lipid pereoxidation products. in vivo, Anal. Biochem. 1983; 130: 431–436
   PubMed Web of Science ®Google Scholar
• Fears R., Baggaley K. H., Alexander R., Morgan B., Hindley R. M. The participation of ethyl 4-benzylloxybenzoate (BRL 10894) and other aryl-substituted acids in glycerolipid metabolism. J. Lipid Res. 1978; 19: 3–11
   PubMed Web of Science ®Google Scholar
• Takashima K., Ohyama K., Mori T., Takeyama S. Hypolipidemic effect of α-mono-p-myristyloxy- α'-methylcinnamoyl glycereol (LK-903) in rats. Biochem. Pharmacol. 1978; 27: 2631–2635
   PubMed Web of Science ®Google Scholar
• Yagasaki K., Okada K., Mochizuki T., Takagi K., Tsutomu I. Effect of 4-(4′-chlorobenzyloxy) benzyinicotinate (KCD-232) on triglyceride and fatty acid metabolism in rats. Biochem. Pharmacol. 1984; 33: 3151–3163
   PubMed Web of Science ®Google Scholar
• Parker R. A., Kariya T., Grisar J. M., Petrow V. 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids. J. Med. Chem. 1977; 20: 731–791
   Google Scholar
• Fears R. Lipophilic xenobiotic conjugates: The pharmacological and toxicological consequences of the participation of drugs and other foreign compounds as substrates in lipid biosynthesis. Prog. Lipid Res. 1985; 24: 177–195
   PubMed Web of Science ®Google Scholar
• Albro P. W., Corbett J. T., Schroeder J., Reddy J. K. β-Oxidation of 2-ethyl-5-carboxypentyl phthalate in rodent liver. Biochim. Biophys. Acta 1987; 923: 196–205
   PubMed Web of Science ®Google Scholar
• Bronfman M., Amigo L., Morales M. N. Activation of hypolipidemic drugs to acyl-coenzyme A thioesters. Biochem. J. 1986; 239: 781–784
   PubMed Web of Science ®Google Scholar
• Lygre T., Aarsaether N., Stensland E., Aarsland A., Berge R. K. Separation and measurement of clofibroyl coenzyme A and clofibric acid in rat liver after clofibrate administration by reverse-phase high-performence liquid chromatography with photodiode array detection. J. Chromatog. 1086; 381: 95–105
   Google Scholar
• Hertz R., Bar-Tana J. The acylation of proteins by xenobiotic amphipathic carboxylic acids in cultured rat hepatocytes. Biochem. J. 1988; 254: 39–44
   PubMed Web of Science ®Google Scholar
• Rao M. S., Lalwani N. D., Watanabe T. K., Reddy J. K. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Cancer Res. 1984; 44: 1072–1076
   PubMed Web of Science ®Google Scholar
• Tsuda H., Moore M. A., Asamoto M., Inoue T., Ito N., Satoh K., Ichihara A., Nakamura T., Amelizad Z., Oesch F. Effect of modifying agents on the phenotypic expression of cytochrome P-450, glutathione S-transferase molecular forms, microsomal epoxide hydrolase, glucosed-phosphate dehydrogenase and γ-glutamyltranspeptidase in rat liver preneoplastic lesions. Carcinogenesis 1988; 9: 547–554
   PubMed Web of Science ®Google Scholar
• Ito N., Fukushima S., Tsuda H. Carcinogenicity and modification of carcinogenic response by BHA, BHT and other antioxidants. CRC Crit. Rev. Toxicol. 1985; 15: 109–150
   Web of Science ®Google Scholar
• Elliott B. M., Dodd N. J.F., Elcombe C. R. Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators. Carcinogenesis 1986; 7: 795–799
   PubMed Web of Science ®Google Scholar
• Fahl W. E., Lalwani N. D., Watanabe T., Goel S. K., Reddy J. K. DNA damage related to increased hydrogen peroxide generation by hypolipidemic drug-induced peroxisomes. Proc. Natl. Acad. Sci. 1984; 81: 7827–7830
   PubMed Web of Science ®Google Scholar
• Kornbrust D. J., Barfknecht T. R., Ingram P. J. Effect of di(2-ethylhexyl)phthalate on DNA repair and lipid peroxidation in rat hepatocytes and on metabolic cooperation in Chinese hamster V-79 cells. Toxicol. Environ. Health 1984; 13: 99–116
   PubMed Web of Science ®Google Scholar
• Martelli A., Ferro M., Marinari V. M., Bassi A. M., Brambilla G. Unscheduled DNA synthesis in primary cultures of peroxidized rat hepatocytes. Med. Sci. Res. 1987; 15: 989–990
   Google Scholar
• Olson M. J. DNA strand breaks induced by hydrogen peroxide in isolated rat hepatocytes. J. Toxicol. Environ. Health 1988; 23: 407–423
   PubMed Web of Science ®Google Scholar
• Bentley P., Bieri F., Mitchell F., Waechter F., Staubli W. Investigations on the mechanism of liver tumour induction by peroxisome proliferators. Arch. Toxicol. Suppl. 1987; 10: 157–161
   PubMedGoogle Scholar
• Williams G. M., Williams H., Maruyama, Tanaka T. Lack of initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate in rat liver carcinogenesis. Carcinogenesis 1987; 8: 875–880
   PubMed Web of Science ®Google Scholar
• Cattley R. C., Marsman D. S., Popp J. A. Failure of the peroxisome proliferator Wy-14,643 to initiate growth-selectable foci in rat liver. Toxicology 1988, in press.
   Web of Science ®Google Scholar
• Rao M. S., Tatematsu M., Subbarao V., Ito N., Reddy J. K. Analysis of peroxisome proliferator-induced preneoplastic and neo-plastic lesions of rat liver for placental form of glutathione S-transferase and γ-glutamyltranspeptidase. Cancer Res. 1986; 46: 5287–5290
   PubMed Web of Science ®Google Scholar
• Rao M. S., Subbarao V., Reddy J. K. Increased resistance of peroxisome proliferator-induced hepatic lesions to iron overload in rats. Cancer Lett. 1986; 32: 33–39
   PubMed Web of Science ®Google Scholar
• Bannasch P. Preneoplastic lesions as endpoints in carcinogenicity testing. I. Hepatic preneoplasia. Carcinogenesis 1986; 7: 689–695
   PubMed Web of Science ®Google Scholar
• Farber E. Pre-cancereous steps in carcinogenesis. Their physiological adaptive nature. Biochim. Biophys. Acta 1984; 738: 171–180
   PubMed Web of Science ®Google Scholar
• Goldsworthy T. L., Hanigan H. M., Pitot H. C. Models of hepatocarcinogenesis in the rat—constraints and comparisons. CRC Crit. Rev. Toxicol. 1986; 17: 61–89
   Web of Science ®Google Scholar
• Kaufmann W. K., MacKenzie S. A., Kauffman D. G. Quantitative relationship between hepatocytic neoplasms and islands of cellular alterations during hepatocarcinogensis in the male F344 rat. Am. J. Pathol. 1985; 119: 171–174
   PubMed Web of Science ®Google Scholar
• Kaufmann W. K., MacKenzie S. A., Rahija R., Kaufman d. G. Quantitative relationship between initiation of hepatocarcinogenesis and induction of altered cell islands. J. Cell. Biochem. 1986; 30: 1–9
   PubMed Web of Science ®Google Scholar
• Kaufmann W. K., Rahija R. J., MacKenzie S. A., Kaufman D. G. Cell cycle-dependent initiation of hepatocarcinogenesis in rats by (±)-7r, 8t-dihydroxyl-9t, 10t-epoxy-7,8,9,10-tetrahydrobenzo(a)-pyrene. Cancer Rex 1987; 47: 3771–3775
   PubMed Web of Science ®Google Scholar
• Watanabe K., Williams G. M. Enhancement of rat hepatocellular-altered foci by the tumor promoter phenobarbital: Evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. J. Natl. Cancer Inst. 1978; 61: 1311–1314
   PubMed Web of Science ®Google Scholar
• Scherer E. Neoplastic progression in experimental hepatocarcinogenesis. Biochim. Biophys. Acta. 1984; 738: 219–236
   PubMed Web of Science ®Google Scholar
• Préat V., de Gerelache J., Lans M., Taper H., Roberfroid M. Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis. Carcinogenesis 1986; 7: 1025–1028
   PubMed Web of Science ®Google Scholar
• Popp J. A., Garvey L. K., Cattley R. C. In vivo studies on the mechanism of di(2-ethylhexyl)phthalate carcinogenesis. Toxicol. Ind. Health 1987; 3: 151–163
   PubMed Web of Science ®Google Scholar
• Préat V., Roberfroid M. Modulation of rat hepatocarcinogenesis by peroxisome proliferators. Second International Conference on Anticarcinogenesis and Radiation Protection, Gaithersburg, MD, March, 1987, 8–12
   Google Scholar
• Mochizuki Y., Furukawa K., Sawada H. Effects of various concentrations of ethyl-α-p-chlorophenoxyisobutyrate (clofibrate) on diethylnitrosamine-induced hepatic tumorigenesis in the rat. Carcinogenesis 1985; 3: 1027–1029
   Google Scholar
• Cattley R. C., Popp J. A. Differences in the hepatic promotional activities of the peroxisome proliferator Wy-14,643 and phenobarbital in rats. Proc. Amer. Assoc. Cancer 1988; 29, abstract 659
   Google Scholar
• Popp J. A., Garvey L. K., Hamm J. E., Swenberg J. A. Lack of hepatic promotional activity by the peroxisomal proliferating hepatocarcinogen di(2-ethylhexyl)phthalate. Carcinogenesis 1985; 6: 141–144
   PubMed Web of Science ®Google Scholar
• Oesterle D., Deml E. Promoting activity of di(2-ethylhe-xyl)phthalate in rat liver foci bioassay. J. Cancer Res. Clin. Oncol. 1988; 114: 133–136
   PubMed Web of Science ®Google Scholar
• Ward J. M., Rice J. M., Creasia D., Lynch P., Riggs C. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice. Carcinogenesis 1983; 4: 1021–1029
   PubMed Web of Science ®Google Scholar
• Ward J. M., Ohshima M., Lynch P., Riggs C. Di(2-ethylhexyl)phthalate but not phenobarbital promotes N-nitrosodiethylamine-initiated hepatocellular proliferative lesions after short-term exposure in male B6C3F1 mice. Cancer Lett. 1984; 24: 49–55
   PubMed Web of Science ®Google Scholar
• Schulte-Hermann R., Timmermann-Trosiener I., Schuppler J. Promotion of spontaneous preneoplastic cell in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res. 1983; 43: 839–844
   PubMed Web of Science ®Google Scholar
• Popp J. A., Scortichini B., Garvey L. K. Quantitative evaluation of hepatic foci of cellular alteration occurring spontaneously in Fischer-344 rats. Fund. Appl. Toxicol. 1985; 5: 314–319
   PubMedGoogle Scholar
• National Toxicology Program. Carcinogenesis bioassay of di(2-ethylhexyl)adipate in F-344 rats and B6C3F1 mice (NTP Technical Report Series No. 212). National Institutes of Health, Bethesda, MD 1982
   Google Scholar
• Ciriolo M. R., Mavelli I., Rotilio G., Borzatta V., Cristofari M., Stanzani L. Decrease of superoxide dismutase and glutathione peroxidase in livers of rats treated with hypolipidemic drugs. FEBS Lett. 1982; 144: 264–268
   PubMed Web of Science ®Google Scholar
• Elliott B. M., Elcombe C. R. Effects of reactive oxygen species produced by peroxisome proliferation in the livers of rats. Proc. Amer. Assoc. Cancer Res. 1985; 281(26, Abstract)
   Google Scholar
• Reddy J. K., Rao M. S., Azamoff D. L., Sell S. Mitogenic and carcinogenic effects of a hypolipidemic peroxisome proliferation, [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643), in rat and mouse liver. Cancer Res. 1979; 39: 152–161
   PubMed Web of Science ®Google Scholar
• Butterworth B. E., Loury D. J., Smith-Oliver T., Cattley R. C. The potential role of chemically-induced hyperplasia in the carcinogenic activity of the hypolipidemic carcinogens. Toxicol. Ind. Health 1987; 3: 129–148
   PubMed Web of Science ®Google Scholar
• Moody D. E., Rao M. S., Reddy J. K. Mitogenic effect in mouse liver induced by a hypolipidemic drug, nafenopin. Virchows Arch. Abt. B 1977; 23: 291–296
   Web of Science ®Google Scholar
• IARC Working Group. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Some Pharmaceutical Drugs. International Agency for Research on Cancer, Lyon 1980; Vol. 24: 39–125
   Google Scholar
• De La Iglesia F. A., Lewis J. E., Buchanan R. A., Marcus E. L., McMahon G. Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment. Atherosclerosis 1982; 43: 19–37
   PubMed Web of Science ®Google Scholar
• Ganning A. E., Brunk U., Dallner G. Phthalate esters and their effect on the liver. Hepatology 1984; 4: 541–547
   PubMed Web of Science ®Google Scholar
• Hanefeld M., Kemmer C. L., Leonhardt W., Kunze K. D., Jaross W., Hailer H. Effects of p-chlorophenoxyisobutyric acid (CPIB) on the human liver. Atherosclerosis 1980; 36: 159–172
   PubMed Web of Science ®Google Scholar
• Blumcke S., Schwartzkopff W., Lobeck h., Edmondson N. A., Prentice D. E., Blane G. F. Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients. Atherosclerosis 1983; 46: 105–116
   PubMed Web of Science ®Google Scholar
• Gariot P., Barrat E., Mejean L., Pointel J. P., Drouin P., Debry G. Fenofibrate and human liver. Arch. Toxicol. 1983; 53: 151–163
   PubMed Web of Science ®Google Scholar
• Gariot P., Barrat E., Drouin P., Genton P., Pointel J. P., Foliquet B., Kolopp M., Debry G. Morphometric study of human hepatic modifications induced by fenofibrate. Metabolism 1987; 36: 203–210
   PubMed Web of Science ®Google Scholar
• Hanefeld M., Kemmer C., Kadner E. Relationship between morphological changes and lipid-lowering action of p-chlorphenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man. Atherosclerosis 1983; 46: 239–246
   PubMed Web of Science ®Google Scholar
• Svoboda D., Grady H., Azarnoff D. Microbodies in experimentally altered cells. J. Cell Biol. 1967; 35: 127–152
   PubMed Web of Science ®Google Scholar
• Gray R. H., De La Iglesia F. A. Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species. Hepatology 1984; 4: 520–530
   PubMed Web of Science ®Google Scholar
• Chemical Manufacturers Association (CMA). CMA reference PE 34.0-MM-BIB. The biochemical, histological and electron-microscopic examination of livers from monkeys. Chemical Manufacturers Association, Washington, DC 1987
   Google Scholar
• Orton T. C., Adam H. K., Bentley M., Holloway B., Tucker M. J. Clobuzarit: Species differences in morphological and biochemical response of the liver following chronic administration. Toxicol. Appl. Pharmacol. 1984; 73: 138–151
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Lalwani N. D., Qureshi S. A., Reddy M. K., Moehle C. M. Induction of hepatic peroxisome proliferation in nonrodent species, including primates. Am. J. Pathol. 1984; 114: 171–182
   PubMed Web of Science ®Google Scholar
• Lalwani N. D., Reddy M. K., Ghosh S., Barnard S. D., Molello J. A., Reddy J. K. Induction of fatty acid P-oxidation and peroxisome proliferation in the liver of rhesus monkeys by DL-040, a new hypolipidemic agent. Biochem. Pharmacol. 1985; 34: 3473–3482
   PubMed Web of Science ®Google Scholar
• Allen K. L., Green C. E., Tyson C. A. Comparative studies of peroxisomal enzyme induction in hepatocytes from rat, cynomolgus monkey and human by hypolipidemic drugs. Toxicologist 1987; 7(abstract 253)
   Google Scholar
• Gray T. J.B., Lake B. G., Beamand J. A., Foster J. R., Gangolli S. D. Peroxisomal effects of phthalate esters in primary cultures of rat hepatocytes. Toxicology 1983; 28: 167
   PubMed Web of Science ®Google Scholar
• Mitchell A. M., Lhuquenot J. C., Bridges J. W., Elcombe C. R. Identification of the proximate peroxisome proliferator(s) derived from di(2-ethylhexyl)phthalate. Toxicol. Appl. Pharmacol. 1985; 80: 23–29
   PubMed Web of Science ®Google Scholar
• Elcombe C. R., Mitchell A. M. Peroxisome proliferation due to di(2-ethylhexyl)phthalate (DEHP): Species differences and possible mechanisms. Envir. Health Perspect. 1986; 70: 211–219
   PubMed Web of Science ®Google Scholar
• Butterworth B. E., Smith-Oliver T., Earle L., Lowry J. J., White R. D., Doolittle D. J., Working P. K., Cattley R. C., Jirtle R., Michalopoulos G, Strom S. S. Use of primary cultures of human hepatocytes in toxicology studies. Cancer Res. 1988, in press.
   Web of Science ®Google Scholar
• Svoboda D. J., Azarnoff D. L. Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug. Cancer Res. 1979; 39: 3419–3428
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Qureshi S. A. Tumorigenicity of the hypolipidemic peroxisome proliferator ethyl-α-p-chlorophenoxyisobutyrate (clofibrate) in rats. Br. J. Cancer 1979; 40: 476–482
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Azamoff D. L., Hignite C. E. Hypolipidemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature (Lond.) 1980; 283: 397–398
   PubMed Web of Science ®Google Scholar
• Reddy J. K., Rao M. S. Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator. J. Natl. Cancer Inst. 1977; 59: 1645–1650
   PubMed Web of Science ®Google Scholar
• Lalwani N. D., Reddy M. K., Qureshi S. A., Reddy J. K. Development of hepatocellular carcinomas and increased peroxisomal fatty acid β-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimi-dinylthiolacetic acid (Wy-14,643) in semipurified diet. Carcinogenesis 1981; 2: 645–650
   PubMed Web of Science ®Google Scholar